The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study
- PMID: 36637538
- DOI: 10.1007/s00431-022-04771-7
The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study
Abstract
Calgranulin-C (S100A12) and zonulin are considered markers of intestinal inflammation. Our aim was to evaluate fecal S100A12 (f-S100A12) and fecal zonulin (f-zonulin) in children with inflammatory bowel disease (IBD), compared to fecal calprotectin (FC) and serum inflammatory markers. We enrolled children with a previous diagnosis of Crohn's disease (CD) and ulcerative colitis (UC). F-S100A12, f-zonulin, and FC were determined by enzyme-linked immunosorbent assay (ELISA). Endoscopic examination was considered in the patients who underwent ileocolonoscopy within 2 weeks from the enrollment. One hundred seventeen children, 39.3% with CD and 60.7% with UC were enrolled. In both CD and UC, there was a significant direct correlation between FC and f-S100A12 levels. In children with CD and UC, both FC and f-S100A12 correlated with markers of serum inflammation. We found difference in FC and f-S100A12 levels between patients in clinical relapse and remission (FC: mean 1027 ± 818 mcg/ml vs 580 ± 695 mcg/ml respectively, p = 0.028; f-S100A12: mean 66.4 ± 48.2 mcg/ml vs 42.7 ± 40 mcg/ml, respectively p = 0.02). Moreover, we found difference in FC between children with endoscopic inflammation and remission (mean 825 ± 779 mcg/ml vs 473.3 ± 492 mcg/ml, respectively p = 0.048), as well as for f-S100A12 (53 ± 43 mcg/ml vs mean 31 ± 33 mcg/ml vs, respectively p = 0.019). No significant results were found for f-zonulin.
Conclusion: Our data suggest that f-S100A12 and FC are both useful non-invasive biomarkers in the management of pediatric IBD in follow up and in monitoring endoscopic and clinical relapse.
What is known: • Fecal calprotectin (FC), fecal S100A12 (f- S100A12), and fecal zonulin represent potential noninvasive markers of gut inflammation. • Since S100A12 is predominantly expressed by granulocytes, high levels of f-S100A12 should be more specific for inflammation than FC.
What is new: • FC and f-S100A12 were correlated to each other and despite the lack of correlation with disease location, they were associated with endoscopic inflammation and clinical relapse in children with IBD. • No significant correlations were found between f-zonulin and the inflammatory parameters.
Keywords: Calgranulin-C; Fecal S100A12; Fecal calprotectin; Fecal zonulin; Inflammatory bowel disease.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Vitamin D for the treatment of inflammatory bowel disease.Cochrane Database Syst Rev. 2023 Oct 2;10(10):CD011806. doi: 10.1002/14651858.CD011806.pub2. Cochrane Database Syst Rev. 2023. PMID: 37781953 Free PMC article.
-
Helminth therapy (worms) for induction of remission in inflammatory bowel disease.Cochrane Database Syst Rev. 2014 Jan 20;2014(1):CD009400. doi: 10.1002/14651858.CD009400.pub2. Cochrane Database Syst Rev. 2014. PMID: 24442917 Free PMC article.
-
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.Health Technol Assess. 2013 Nov;17(55):xv-xix, 1-211. doi: 10.3310/hta17550. Health Technol Assess. 2013. PMID: 24286461 Free PMC article.
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
Prebiotics for induction and maintenance of remission in ulcerative colitis.Cochrane Database Syst Rev. 2024 Mar 19;3(3):CD015084. doi: 10.1002/14651858.CD015084.pub2. Cochrane Database Syst Rev. 2024. PMID: 38501688 Free PMC article.
Cited by
-
Role of Intestinal Inflammation and Permeability in Patients with Acute Heart Failure.Medicina (Kaunas). 2023 Dec 20;60(1):8. doi: 10.3390/medicina60010008. Medicina (Kaunas). 2023. PMID: 38276042 Free PMC article.
-
Markers of Intestinal Permeability and Inflammation in Enterally Fed Children with Cerebral Palsy.Nutrients. 2024 Jul 27;16(15):2447. doi: 10.3390/nu16152447. Nutrients. 2024. PMID: 39125328 Free PMC article.
-
Assessment of Intestinal Permeability and Inflammation Bio-Markers in Patients with Rheumatoid Arthritis.Nutrients. 2023 May 19;15(10):2386. doi: 10.3390/nu15102386. Nutrients. 2023. PMID: 37242269 Free PMC article.
References
-
- Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen , Dobos GJ (2005) Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflammatory Bowel Dis 11(12):1085–1091. https://doi.org/10.1097/01.MIB.0000187980.08686.18
-
- Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G (2017) Faecal calprotectin measurement is a marker of short term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World J Gastroenterol 23(41):7387–7396 - PubMed - PMC - DOI
-
- Johne B, Kronborg O, Tøn HI, Kristinsson J, Fuglerud P (2001) A new faecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol 36:291–296
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous